Diamyd develops pharmaceuticals for the treatment of autoimmune diabetes and its complications. Our vision is to one day be able to prevent and cure the autoimmune form of diabetes. Diamyd's lead product, the diabetes vaccine Diamyd® has shown to significantly slow down the disease process.
Feedback